Format

Send to

Choose Destination
Int J Clin Pharm. 2015 Oct;37(5):678-81. doi: 10.1007/s11096-015-0148-6.

Recommendations to support deprescribing medications late in life.

Author information

1
Division of Pharmacy, School of Medicine, Pharmacy and Health, Durham University, Queen's Campus, Stockton-on-Tees, UK. adam.todd@durham.ac.uk.
2
Department of General Internal Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Abstract

It is widely acknowledged that patients-particularly those late in life-are frequently exposed to the harms of medication. To minimize these harms, several frameworks have been developed by which prescribing can be optimized. In the context of diminishing life expectancy, these frameworks can be used to reduce medications that are no longer necessary, but appear to fall short of actual guidelines that incorporate a consideration of stopping medications. In this commentary, we present recommendations that could be incorporated into prescribing processes for all healthcare professionals and, ultimately, used to support the rationalization or deprescribing of medication in diminished life expectancy. We frame these recommendations in the same context as guidance for the initiation and discontinuation of implantable cardiac devices and argue that the two processes-with regards to decision-making-should be the same. We present our recommendations with preventive medication use in mind, and use statin therapy as an illustrative example.

KEYWORDS:

Deprescribing; Polypharmacy; Rationalizing medications

PMID:
26078120
PMCID:
PMC4682203
DOI:
10.1007/s11096-015-0148-6
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center